ClinConnect ClinConnect Logo
Search / Trial NCT03832387

Non-invasive Ventilation vs Oxygen Therapy After Extubation Failure

Launched by FUNDACIÓN PARA EL FOMENTO DE LA INVESTIGACIÓN SANITARIA Y BIOMÉDICA DE LA COMUNITAT VALENCIANA · Feb 4, 2019

Trial Information

Current as of June 07, 2025

Completed

Keywords

Non Invasive Mechanical Ventilation Oxygen Therapy Extubation Failure

ClinConnect Summary

Patients. Medical and surgical patients admitted to intensive care unit with 18 years of age or older in weaning from their first episode of mechanical ventilation for more than 24 hours were included. Patients with structural neurological disorder, acute toxic-metabolic neurological encephalopathy with neurological deficit \[estimated by a Glasgow Coma Score \<14 points\] at the time of weaning, neuromuscular disease, chronic obstructive pulmonary disease receiving non-invasive ventilation, limitation of life support therapy during their admission, tracheostomized patients, spinal cord inj...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Medical and surgical ICU patients with 18 years of age or older
  • First episode of mechanical ventilation for more than 24 hours
  • Exclusion Criteria:
  • Structural neurological disorder
  • Acute toxic-metabolic neurological encephalopathy with neurological deficit \[estimated by a Glasgow Coma Score (GCS) \<14 points\] at the time of weaning
  • Neuromuscular disease
  • Chronic obstructive pulmonary disease (COPD) receiving NIV
  • Limitation of life support therapy during their admission
  • Tracheostomized patients
  • Spinal cord injuries
  • Scheduled surgical procedure during the 48 hours following extubation
  • Intensive care unit readmission
  • Transfer to another centre
  • Contraindication to non-invasive mechanical ventilation

About Fundación Para El Fomento De La Investigación Sanitaria Y Biomédica De La Comunitat Valenciana

The Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana is a prominent clinical trial sponsor dedicated to advancing health research in the Valencian Community. By fostering collaboration between healthcare institutions, academic entities, and industry partners, the foundation aims to enhance biomedical innovation and improve public health outcomes. With a focus on prioritizing patient welfare and ethical research practices, it actively supports the development of cutting-edge therapies and medical solutions through rigorous clinical trials and research initiatives.

Locations

Castellón De La Plana, Castello, Spain

Patients applied

0 patients applied

Trial Officials

ALBERTO BELENGUER MUNCHARAZ

Principal Investigator

HOSPITAL GENERAL UNIVERSITARIO CASTELLON

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials